HomeRAPP • NASDAQ
Rapport Therapeutics Inc
add
$9.96
2.10%
After Hours:(0.00%)0.00
$9.96
Closed: May 16, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.11M | 58.58% |
Net income | -24.06M | -6.15% |
Net profit margin | — | — |
Earnings per share | -0.68 | — |
EBITDA | -26.86M | -58.56% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 285.38M | 47.68% |
Total assets | 302.05M | 46.42% |
Total liabilities | 16.22M | 45.01% |
Total equity | 285.84M | — |
Shares outstanding | 36.50M | — |
Price to book | 1.25 | — |
Return on assets | -21.97% | — |
Return on capital | -22.57% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -24.06M | -6.15% |
Cash from operations | -20.24M | -14.89% |
Cash from investing | 21.03M | 150.16% |
Cash from financing | 5.00K | -99.99% |
Net change in cash | 799.00K | -80.60% |
Free cash flow | -13.67M | -22.73% |
Previous close
$9.76
Day range
$9.76 - $10.29
Year range
$6.43 - $29.74
Market cap
363.52M USD
Avg Volume
154.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2022
Headquarters
Website
Employees
69
